Trial Profile
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ACTS-GC
- Sponsors Taiho Pharmaceutical
- 27 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2010 According to a Taiho Pharmaceutical media release, the five-year follow-up results of this trial were presented at the meeting of the European Society for Medical Oncology (ESMO-2010).
- 15 Oct 2010 According to a Taiho Pharmaceutical media release, these results are expected to be reported at the 48th Annual Meeting of the Japan Society of Clinical Oncology.